Gene therapy trial aims to turn back the clock on aging
NCT ID NCT07285629
First seen Jan 11, 2026 · Last updated May 10, 2026 · Updated 20 times
Summary
This early-stage study tests a new gene therapy in 30 healthy adults aged 50 to 80. The therapy uses a harmless plasmid to deliver genes for klotho and follistatin, proteins linked to aging and health. Researchers will check safety and measure protein levels in the blood, along with quality of life changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Apeiron Center
RECRUITINGAustin, Texas, 78701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Global Alliance of Regenerative Medicine (GARM) Clinic
NOT_YET_RECRUITINGRoatán, Bay Islands, Honduras
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.